These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3500331

  • 1. [Lymphocyte subsets and response of breast cancer and benign mammary disease to PHA].
    Nakao S, Hayashida K, Hasegawa H, Ishii T, Eida K, Noguchi K.
    Gan No Rinsho; 1987 Oct; 33(12):1453-8. PubMed ID: 3500331
    [Abstract] [Full Text] [Related]

  • 2. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
    Mantovani G, Serri FG, Macciò A, Castelli P, Benedetti P, Scambia G, Santus S, Paderi R, Murtas MG, Ferreli A.
    Cancer Detect Prev; 1989 Oct; 13(5-6):323-32. PubMed ID: 2743354
    [Abstract] [Full Text] [Related]

  • 3. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
    Gupta S, Cunningham-Rundles S.
    J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
    [Abstract] [Full Text] [Related]

  • 4. [Quantitative variations of lymphocyte subsets in various kinds of cancer patients in the terminal stage].
    Nakajima Y, Akimoto M, Iwasaki H, Matano S, Hirakawa H, Kimura M.
    Gan No Rinsho; 1986 Dec; 32(15):1925-8. PubMed ID: 3806964
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G, Spuzić I.
    Srp Arh Celok Lek; 1995 Dec; 123(9-10):227-31. PubMed ID: 17974436
    [Abstract] [Full Text] [Related]

  • 8. Lymphocyte reactivity to mitogens and tumor sex steroid receptors in breast cancer patients.
    Kastelan M, Rudolf M, Hrsak M, Stojkovic R, Gamulin S.
    Biomed Pharmacother; 1985 Dec; 39(8):442-4. PubMed ID: 3834952
    [Abstract] [Full Text] [Related]

  • 9. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
    Nowak JS, Lanzrein C.
    Neoplasma; 1984 Dec; 31(3):281-9. PubMed ID: 6610835
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppressive activity of lymphocyte mitogenesis by breast cancer-associated p43.
    Reinerová M, Veselovská Z, Ausch C, Rosen HR.
    Neoplasma; 1996 Dec; 43(6):363-6. PubMed ID: 8996559
    [Abstract] [Full Text] [Related]

  • 11. Variability of lymphocyte response to PHA in patients with operable breast carcinoma: effect of cell concentration, PHA dose, serum and period of cultivation.
    Harrison RA, Lee H, Farrant J.
    Clin Oncol; 1981 Sep; 7(3):205-12. PubMed ID: 7343166
    [No Abstract] [Full Text] [Related]

  • 12. Enhanced viral inhibition of lymphocyte mitogenesis in patients with advanced breast cancer.
    Margolese RG, Wainberg MA.
    Clin Exp Immunol; 1985 Oct; 62(1):85-94. PubMed ID: 2998661
    [Abstract] [Full Text] [Related]

  • 13. [Cellular immunity indices in benign breast tumors].
    Baisheva SA, Zhalgasbaeva GT, Kaliev IuSh, Mezinova NN.
    Vopr Onkol; 1980 Oct; 26(5):15-9. PubMed ID: 7385708
    [Abstract] [Full Text] [Related]

  • 14. [The effect of human cord plasma on the incorporation of 3H-thymidine by PHA-stimulated peripheral blood lymphocytes of cervical cancer patient (author's transl)].
    Fujii S, Nakashima N, Kobayashi H, Mori T, Nishimura T.
    Acta Obstet Gynaecol Jpn; 1980 Dec; 32(12):1945-50. PubMed ID: 7211212
    [Abstract] [Full Text] [Related]

  • 15. Cellular antitumor immune response in women with risk factors for breast cancer.
    Sanner T, Brennhovd I, Christensen I, Jørgensen O, Kvaløy S.
    Cancer Res; 1979 Feb; 39(2 Pt 2):654-7. PubMed ID: 761231
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-2 activity and the response of peripheral blood lymphocytes in patients with gynecologic malignancies.
    Iwano I, Kikuchi Y, Oomori K, Kizawa I, Kita T, Kato K.
    Cancer Detect Prev; 1988 Feb; 12(1-6):583-8. PubMed ID: 3263201
    [Abstract] [Full Text] [Related]

  • 17. Lymphocyte transformation in patients with breast cancer.
    Whittaker MG, Clark CG.
    Br J Surg; 1971 Apr; 58(4):302. PubMed ID: 5572347
    [No Abstract] [Full Text] [Related]

  • 18. Identification of women with early breast cancer by analysis of p43-positive lymphocytes.
    Auerbach L, Hellan M, Stierer M, Rosen AC, Ausch C, Obwegeser R, Kubista E, Wolf G, Rosen HR, Panzer S.
    Br J Cancer; 1999 May; 80(5-6):874-8. PubMed ID: 10360668
    [Abstract] [Full Text] [Related]

  • 19. [Activity of non-specific T-suppressors regulating the proliferation of B- and T-lymphocytes in patients with fibroadenomatosis, breast cancer and stomach cancer].
    Grinevich IuA, Drannik GN, Nikol'skiĭ IS, Kalinina NA, Litvishchenko EI.
    Vopr Onkol; 1984 May; 30(12):23-7. PubMed ID: 6240157
    [Abstract] [Full Text] [Related]

  • 20. Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.
    de Cremoux P, Extra JM, Denis MG, Pierga JY, Bourstyn E, Nos C, Clough KB, Boudou E, Martin EC, Müller A, Pouillart P, Magdelénat H.
    Clin Cancer Res; 2000 Aug; 6(8):3117-22. PubMed ID: 10955792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.